Global Clinical Microbiology Market

Clinical Microbiology Market: Insights

During the forecast timeline from 2020 to 2026, the worldwide market for clinical microbiology will be powered by a strong compound annual growth rate. The analysis of any microbe that causes human infection is described as clinical microbiology. It helps to explain the disorder by studying the disease-related molecular pathways. It includes aspects of microbiology relevant to the treatment of patients with any microorganisms that are contaminated. The increasing numbers of infectious diseases, along with the high rise in the number of patients with disorders are some of the major factors expected to drive the growth of the clinical microbiology market. Clinical microbiology is specifically concerned with infectious disease control, diagnosis, and treatment. Moreover, the growing surge of contagious disease outbreak is also driving the market growth. Furthermore, the growing awareness of health concerns and increasing acceptance of technological advancements in microbiology testing are some of the factors expected to push the market growth. However, strict rules from the government, lack of skilled professionals, and delaying the clearance of microbiology diagnostic tests diverse regulatory structures that are likely to adversely affect market growth during the forecast timeframe.

Clinical Microbiology Market: By Diseases

This market can be explained into four segments based on the disease type analysis, namely; respiratory diseases, bloodstream diseases, gastrointestinal diseases, sexually transmitted diseases, periodontal diseases, urinary tract infections, and other indications. The respiratory diseases segment accounts for a strong-growth rate of this industry segment. With rising industrialization, rising levels of air pollution are contributing to a rapid rise in the incidence of respiratory diseases. Moreover, in both developed and emerging countries, the prevalence of infectious diseases is high is another primary factor driving positive growth in the industry.

Clinical Microbiology Market: By Application

The industry is fragmented into application-based divisions namely; energy applications, pharmaceutical applications, food testing applications, chemical & material manufacturing, clinical applications, and environmental applications. Of all applications, the use of pharmaceuticals adds the most to the market's global revenue. The rising number of imported prescription drugs worldwide is one of the critical factors expected to anticipate the market growth for the pharmaceutical segment. Furthermore, it has been due to the existence of well-established and globally known regulations regulating the assessment of microbial contamination during the processing of pharmaceutical and raw materials.

Clinical Microbiology Market: By Product Type

Based on the study of product type, this market can be explained into instruments, and further segmented into laboratory instruments, microbial analyzer, and reagents. The growth of the laboratory instruments division would be quicker than the latter. The increasing collaborations between industry and academia for genomic science clubbed with the technical advancements in the study of molecular techniques are some of the factors expected to boost the market growth.

Clinical Microbiology Market: By End-User

Based on the study of end-user, this market can be explained into hospitals & diagnostics centers, academic & research institutes, and custom lab service providers, among others. The hospitals & diagnostics centers segment accounts for the largest market share industry segment. This is due to the high prevalence of target diseases clubbed with the availability of technologically sophisticated items for infectious diseases.

Clinical Microbiology Market: By Region

The clinical microbiology market is classified into Europe, Asia Pacific, MEA, CSA, and North America depending on the geographical area. The North America area is the main sales contributor in the sector over the forecast timeframe. Some of the factors influencing the market growth are rising healthcare costs and high penetration among key end-users of clinical microbiology technologies. Furthermore, due to the increased participation of general practitioners, the vast patient population, and developments in technology, the Asia-Pacific region is projected to be the fastest-growing region at a high CAGR rate. Moreover, the growing prevalence of chronic diseases is expected to fuel demand growth in the APAC region in countries such as India and China, along with the increasing investment in healthcare infrastructure

Clinical Microbiology Market Share & Competitor Analysis

The key players in this market are bioMérieux, Abbott Laboratories, Hardy Diagnostics, Bruker Corporation, New Horizons, Bio-Rad Laboratories, OpGen, Becton, Dickinson and Company, Thermo Fisher Scientific, Hologic, Agilent Technologies, 3M, Memmert, Roche Diagnostics, Liofilchem, Vacutest Kima, Vacutest Kima, QIAGEN, Shimadzu Corporation, TCS Biosciences, Biotechnology Solutions, Arrow Diagnostics, and NEOGEN Corporation, among others.

Please note: This is not an exhaustive list of companies profiled in the report.

In February 2019, bioMérieux has successfully acquired Invisible Sentinel. The company is engaged in the marketing, manufacturing, and development of molecular diagnostic tools.

Check the Press Release on Global Clinical Microbiology Market Report